Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas
Khyati Meghani, Walker Fuchs, Alexandre Detappe, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 100-111
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

PARP and PARG inhibitors in cancer treatment
Dea Slade
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 360-394
Open Access | Times Cited: 525
PARP inhibitor resistance: the underlying mechanisms and clinical implications
He Li, Zhaoyi Liu, Nayiyuan Wu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 355
Replication Gaps Underlie BRCA Deficiency and Therapy Response
Nicholas J. Panzarino, John J. Krais, Ke Cong, et al.
Cancer Research (2020) Vol. 81, Iss. 5, pp. 1388-1397
Open Access | Times Cited: 156
Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
Antonios Revythis, Anu Limbu, Christos Mikropoulos, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8577-8577
Open Access | Times Cited: 84
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
Emine Bayraktar, Recep Bayraktar, Hülya Öztatlıcı, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 2, pp. 27-27
Open Access | Times Cited: 56
Ovarian Cancer—Insights into Platinum Resistance and Overcoming It
Andrei Havași, Simona Căinap, Ana Teodora Havasi, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 544-544
Open Access | Times Cited: 54
Drug resistance in ovarian cancer: from mechanism to clinical trial
Ling Wang, Xin Wang, Xueping Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 54
PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
Man Yee Keung, Yanyuan Wu, Jaydutt V. Vadgama
Journal of Clinical Medicine (2019) Vol. 8, Iss. 4, pp. 435-435
Open Access | Times Cited: 136
Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition
Brittany Haynes, Junko Murai, Jung‐Min Lee
Cancer Treatment Reviews (2018) Vol. 71, pp. 1-7
Open Access | Times Cited: 105
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer
Feiyue Zheng, Yi Zhang, Shuang Chen, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 123, pp. 109661-109661
Open Access | Times Cited: 104
The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
Shuangying Li, Liangliang Wang, Yuanyuan Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 63
Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors
Negesse Mekonnen, Hobin Yang, Young Kee Shin
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 58
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status
Yongsong Wu, Shilin Xu, Shanshan Cheng, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 38
MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies
Hyun Ah Seo, Sokviseth Moeng, Seokmin Sim, et al.
Cells (2019) Vol. 9, Iss. 1, pp. 29-29
Open Access | Times Cited: 70
Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 64
PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies
Elizabeth K. Lee, Ursula A. Matulonis
Cancers (2020) Vol. 12, Iss. 8, pp. 2054-2054
Open Access | Times Cited: 64
Revisiting the BRCA-pathway through the lens of replication gap suppression
Sharon B. Cantor
DNA repair (2021) Vol. 107, pp. 103209-103209
Open Access | Times Cited: 46
R-Loops and R-Loop-Binding Proteins in Cancer Progression and Drug Resistance
Noha Elsakrmy, Haissi Cui
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7064-7064
Open Access | Times Cited: 17
Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis
Josep Marí‐Alexandre, Amador CARCELEN, Cristina Agababyan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5322-5322
Open Access | Times Cited: 49
The role of PARP inhibitors in BRCA mutated pancreatic cancer
Jeffrey Chi, Su Yun Chung, Ruwan Y. Parakrama, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 37
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
Elisa Martino, Nunzia D’Onofrio, Camilla Anastasio, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 371-384
Open Access | Times Cited: 16
PARP Inhibitors and the Evolving Landscape of Ovarian Cancer Management: A Review
Sarah Cook, Anna V. Tinker
BioDrugs (2019) Vol. 33, Iss. 3, pp. 255-273
Closed Access | Times Cited: 42
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer
Elizabeth H. Stover, Maria B. Baco, Ofir Cohen, et al.
Molecular Cancer Research (2019) Vol. 17, Iss. 11, pp. 2281-2293
Open Access | Times Cited: 41
Jack of all trades? The versatility of RNA in DNA double-strand break repair
Ruth F. Ketley, Monika Gullerová
Essays in Biochemistry (2020) Vol. 64, Iss. 5, pp. 721-735
Open Access | Times Cited: 36
Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles
Kevin M. Elias, Urszula Smyczyńska, Konrad Stawiski, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top